Elevance Health Inc. ($ELV) Stock Forecast: Up 5.1% Today

What is Elevance Health Inc.?

Elevance Health (NYSE: ELV) is a significant U.S. health benefits company that has been facing challenges in the market due to regulatory issues with CMS regarding Medicare Advantage drug plans and a decline in Medicare Advantage members. Despite these hurdles, Wall Street analysts remain optimistic about its future prospects.

Why is Elevance Health Inc. going up?

ELV stock is up 5.1% on Mar 10, 2026 17:11

• ELV stock experienced a strong bullish movement today.
• Pinkerton Wealth LLC significantly increased its stake in Elevance Health, indicating confidence in the company's market position and growth potential, which likely contributed to the positive market sentiment.
• The reaffirmation of financial guidance by Centene Corp, a company specializing in health insurance programs, could have also positively influenced ELV's stock as it reflects stability and growth in the healthcare sector.
• The reduction in stake by the Swiss National Bank might have initially raised concerns, but the overall market sentiment seems to have been buoyed by the increased confidence shown by Pinkerton Wealth LLC and the positive industry outlook.

ELV Price Chart

ELV Technical Analysis

ELV News

Elevance Health Stock Fell 32% Last Year. Do Analysts See Recovery?

Elevance Health's stock fell 32% last year and is currently trading 39% below its 52-week high due to regulatory issues with CMS regarding Medicare Advantage drug plans and an anticipated decline in Medicare Advantage members. Despite these challenges, Wall Street analysts maintain a positive outlook with a mean price target implying 37.3% upside, underpinned by a projected EPS recovery in 2027 and strong performance from its Carelon Services platform. The critical near-term factor for recovery is the resolution of the CMS deadline on March 31, 2026.

https://www.tikr.com/blog/elevance-health-stock-fell-32-last-year-do-analysts-see-recovery

Pinkerton Wealth LLC Boosts Elevance Health Stake

Pinkerton Wealth LLC has significantly increased its stake in Elevance Health (NYSE: ELV) by 53.8%, adding 4,005 shares in the third quarter of 2026. The investment firm now holds 11,444 shares valued at $3.7 million, reflecting confidence in the healthcare company's strong market position and growth potential. This move signals a positive market sentiment for Elevance Health, which is a major health benefits provider in the U.S.

https://nationaltoday.com/us/in/indianapolis/news/2026/03/10/pinkerton-wealth-llc-boosts-elevance-health-stake/

Swiss National Bank Trims Elevance Health Holdings

The Swiss National Bank has reduced its stake in Elevance Health, Inc. by 5% during the third quarter of 2026, selling 34,000 shares. This move by a major institutional investor could indicate shifting market trends or investor sentiment regarding Elevance Health's performance and outlook, although the precise reasons for the reduction are not fully disclosed. Elevance Health is a significant U.S. health benefits company, making such ownership changes noteworthy for the broader market.

https://nationaltoday.com/us/in/indianapolis/news/2026/03/10/swiss-national-bank-trims-elevance-health-holdings/

Pinkerton Wealth LLC Purchases 4,005 Shares of Elevance Health, Inc. $ELV

Pinkerton Wealth LLC significantly increased its stake in Elevance Health (NYSE:ELV) by 53.8% in the third quarter, acquiring an additional 4,005 shares, bringing their total holdings to 11,444 shares valued at approximately $3.70 million. Other institutional investors also raised their positions, and now institutional investors collectively own 89.24% of the company. Elevance Health reported strong Q3 earnings, beating EPS estimates, and has a "Moderate Buy" consensus rating with an average target price of $390.55, despite recent stock price fluctuations.

https://www.marketbeat.com/instant-alerts/filing-pinkerton-wealth-llc-purchases-4005-shares-of-elevance-health-inc-elv-2026-03-10/

Centene Corp reaffirms 2026 GAAP diluted EPS guidance of over $1.98 and adjusted EPS of over $3.00

Centene Corp has reaffirmed its financial guidance for 2026, expecting GAAP diluted EPS to be over $1.98 and adjusted EPS to be over $3.00. This news comes as several analysts have recently adjusted their price targets for Centene, with varying ratings from Buy to Hold and Equalweight. The company specializes in developing health insurance programs and providing specialized health services.

https://www.marketscreener.com/news/centene-corp-reaffirms-2026-gaap-diluted-eps-guidance-of-over-1-98-and-adjusted-eps-of-over-3-00-ce7e5fded188f020

Trending Today

Ethereum ($ETH) Crypto Forecast: Down 5.5% Today

Dogecoin ($DOGE) Crypto Forecast: Down 5.3% Today

Elevance Health Inc. Price History

10.02.2026 - ELV Stock was up 5.1%

• ELV stock experienced a strong bullish movement today.
• Pinkerton Wealth LLC significantly increased its stake in Elevance Health, indicating confidence in the company's market position and growth potential, which likely contributed to the positive market sentiment.
• The reaffirmation of financial guidance by Centene Corp, a company specializing in health insurance programs, could have also positively influenced ELV's stock as it reflects stability and growth in the healthcare sector.
• The reduction in stake by the Swiss National Bank might have initially raised concerns, but the overall market sentiment seems to have been buoyed by the increased confidence shown by Pinkerton Wealth LLC and the positive industry outlook.

24.01.2026 - ELV Stock was down 5.2%

• The bearish movement in ELV stock could be attributed to profit-taking by investors after a recent bullish run or concerns about the company's growth prospects.
• The commitment of Elevance Health Foundation to funding food as medicine programs may have diverted investor attention away from ELV, impacting its stock performance negatively.
• Investors may be cautious about ELV's position in the market following news of competitors like Alignment Healthcare reporting membership gains and positive earnings growth.
• The broader market sentiment influenced by news of Humana's weaker earnings outlook and regulatory risks may have also contributed to the bearish trend in ELV stock.

03.02.2026 - ELV Stock was down 6.9%

• Today's downward trend in Elevance Health's stock (ELV) can be attributed to various factors:
• Uncertainty arising among investors due to the recent leadership changes and business consolidation.
• Investors viewing the increased regulatory focus on Elevance Health's Medicare Advantage plans as a potential risk factor.
• The positive news of the company raising its quarterly dividend and having a consensus price target above the current trading price may be overshadowed by ongoing regulatory actions and operational adjustments, contributing to the bearish market movement.

03.02.2026 - ELV Stock was down 6.4%

• The bearish movement in Elevance Health's stock today can be attributed to the threat of Medicare Advantage sanctions by CMS due to noncompliance with data submission requirements, which poses financial and reputational risks for the company.
• The positive news of increased investments by Harvest Portfolios Group Inc. and the South Dakota Investment Council may not have been enough to offset the concerns raised by the CMS sanctions, leading to a decline in investor confidence.
• The launch of a national pilot program to provide free diapers by Elevance Health's subsidiary, Elevance Health, could be seen as a positive social initiative but might not have directly impacted the stock movement significantly.
• Overall, the market sentiment towards Elevance Health seems to be influenced more by regulatory challenges and compliance issues rather than positive investment signals, leading to the bearish movement in the stock today.

27.00.2026 - ELV Stock was down 8.1%

• Vanguard Personalized Indexing Management LLC and Barlow Wealth Partners Inc. notably decreased their holdings in Elevance Health, aligning with the downward market trend.
• A proposed flat Medicare Advantage payment rate increase by the Trump administration for 2027, falling short of expectations, has impacted Elevance Health and other major health insurers, leading to a decline in stock value.
• While some institutional investors like Whittier Trust Co. divested their shares, Norges Bank and Vanguard Group increased their positions, reflecting mixed investor sentiment.
• The regulatory announcement's potential effects on Humana and other insurers have added to the negative market sentiment in the healthcare sector and influenced Elevance Health's stock performance.

27.00.2026 - ELV Stock was down 12.4%

• The bearish movement in ELV's stock can be attributed to the proposed flat rates for Medicare Advantage plans by the government, impacting major health insurers.
• Recent decisions by health insurers to adjust Medicare Advantage benefits and underwhelming Q4 performance reports have contributed to negative sentiment in the sector.
• Institutional investors have shown varying stances on ELV, with some reducing their stake while others increasing their position.
• The regulatory announcement regarding Medicare payment rate increases for 2027 has put pressure on healthcare companies reliant on Medicare Advantage plans, leading to a bearish trend in ELV's stock price.

27.00.2026 - ELV Stock was down 14.2%

• Elevance Health (ELV) experienced a strong bearish movement likely due to the broader sector-wide selloff following proposed changes in Medicare Advantage payment rates for 2027.
• The reduction in Medicare Advantage benefits by other companies, in response to disappointing reimbursement rates, further added to the negative sentiment surrounding healthcare stocks, including ELV.
• A reduction in stake by an institutional investor in Elevance Health could have also contributed to the downward pressure on the stock, signaling decreased institutional confidence in the company amidst regulatory uncertainty and market volatility.
• The upcoming earnings report of another company, and its recent poor financial performance leading to a new 52-week low, might have influenced investor sentiment towards riskier assets like ELV, contributing to the bearish movement.

28.00.2026 - ELV Stock was up 5.4%

• Elevance Health (ELV) saw a strong bullish movement following a positive reaction to surpassing profit expectations for Q4 2025.
• Despite a mix of results with profits exceeding expectations but revenues falling short investor confidence surged as the company focuses on affordability and platform enhancements.
• Analysts and investors found reassurance in the company's ability to outperform profit expectations and maintain a positive earnings per share outlook for 2026 amidst revenue growth challenges and margin pressures.
• The market shift may have been influenced by general sentiment towards the healthcare and insurance sectors, weighing concerns about margin risks and membership attrition against the company's profit beat and earnings forecast.

28.00.2026 - ELV Stock was up 5.1%

• ELV stock saw an upward trend driven by investors' favorable response to the company exceeding profit expectations in the fourth quarter of 2025.
• The strong performance in earnings per share, which outperformed analyst predictions, likely contributed to the optimistic market sentiment.
• Despite falling short of revenue targets, the emphasis on affordability and the earnings per share guidance of at least $25.50 for 2026 may have reassured investors about the company's future trajectory.
• Positive analyst evaluations and market outlooks appeared to have boosted investor confidence in ELV, influencing the bullish movement in the market.

27.01.2026 - ELV Stock was down 5.5%

• Speculations arose relating to investor concerns prompted by Close Asset Management Ltd's substantial reduction in ELV shares, potentially influencing the bearish market trend.
• The stock's reaffirmed 2026 earnings outlook might not have resonated positively with investors, resulting in a lack of favorable sentiment towards the company.
• Despite Elevance Health's emphasis on responsible AI integration and financial openness, negative market response to the management reshuffle announcements may indicate investor hesitancy.
• The focus on an educational seminar collaboration between Amlan International and Elanco could have diverted attention from Elevance Health, negatively affecting its stock performance as investors turned towards other industry players.

02.02.2026 - ELV Stock was down 4.9%

• The bearish movement in Elevance Health's stock today is linked to CMS imposing sanctions on the company, suspending Medicare enrollment for alleged noncompliance with risk adjustment data submission requirements.
• Despite surpassing quarterly EPS estimates and increasing its dividend, the adverse impact of CMS sanctions appears to overshadow the positive financial performance.
• The contrasting actions of institutional investors, with one increasing its stake significantly while another reducing its holdings, may have contributed to the uncertainty surrounding the stock.
• Elevance Health's efforts to collaborate with CMS and address compliance issues are acknowledged, but market sentiment seems cautious due to impending sanctions impacting the company's Medicare Advantage plans.

12.01.2026 - ELV Stock was up 4.2%

• ELV stock showed a significant bullish movement recently, potentially influenced by various factors:
• Wealthfront Advisers LLC notably increased its stake in ELV, suggesting optimism regarding the company's future prospects and financial performance.
• Although Zacks Research lowered its EPS forecast, ELV surpassed earnings expectations in the last quarter, raised its dividend, likely boosting investor confidence.
• Analysts' "Moderate Buy" rating and an average price target of $390.55 indicate a positive sentiment towards ELV, potentially contributing to the recent stock movement.
• The company's ability to maintain robust performance despite challenges from a shrinking customer base demonstrates resilience and growth potential, appealing to investors seeking opportunities in a competitive market.